Sharecare (SHCR) Stock Forecast, Price Target & Predictions
SHCR Stock Forecast
Sharecare stock forecast is as follows: an average price target of $3.14 (represents a 122.70% upside from SHCR’s last price of $1.41) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
SHCR Price Target
The average price target for Sharecare (SHCR) is $3.14 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $1.43. This represents a potential 122.70% upside from SHCR's last price of $1.41.
SHCR Analyst Ratings
According to 3 Wall Street analysts, Sharecare's rating consensus is 'Buy'. The analyst rating breakdown for SHCR stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sharecare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 24, 2024 | Craig Hettenbach | Morgan Stanley | $1.43 | $1.37 | 4.38% | 1.42% |
| Nov 11, 2022 | - | Canaccord Genuity | $3.00 | $1.73 | 73.41% | 112.77% |
| Oct 05, 2022 | David Larsen | BTIG | $5.00 | $2.04 | 145.10% | 254.61% |
The latest Sharecare stock forecast, released on Jun 24, 2024 by Craig Hettenbach from Morgan Stanley, set a price target of $1.43, which represents a 4.38% increase from the stock price at the time of the forecast ($1.37), and a 1.42% increase from SHCR last price ($1.41).
Sharecare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $1.43 | $1.43 |
| Last Closing Price | $1.41 | $1.41 | $1.41 |
| Upside/Downside | -100.00% | 1.42% | 1.42% |
In the current month, the average price target of Sharecare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sharecare's last price of $1.41. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 24, 2024 | Morgan Stanley | Buy | Buy | Hold |
| Jun 24, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Apr 01, 2024 | BTIG | Buy | Neutral | Downgrade |
| Nov 11, 2022 | Canaccord Genuity | Buy | Buy | Hold |
| Oct 05, 2022 | BTIG | Buy | Buy | Hold |
Sharecare's last stock rating was published by Morgan Stanley on Jun 24, 2024. The company gave SHCR a "Buy" rating, the same as its previous rate.
Sharecare Financial Forecast
Sharecare Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $105.28M | - | $110.35M | $116.30M | $123.26M | $114.62M | - | $100.71M | $118.54M | $105.62M | - |
| Avg Forecast | $118.60M | $115.80M | $102.10M | $98.30M | $110.95M | $106.50M | $94.50M | $101.53M | $115.00M | $113.68M | $109.77M | $110.90M | $120.25M | $109.07M | $102.91M | $96.94M | $121.05M | $103.52M | $95.70M |
| High Forecast | $118.60M | $115.80M | $102.10M | $98.30M | $110.95M | $106.50M | $94.50M | $101.53M | $115.00M | $113.68M | $109.77M | $110.90M | $120.25M | $109.07M | $102.91M | $97.32M | $121.53M | $103.93M | $96.08M |
| Low Forecast | $118.60M | $115.80M | $102.10M | $98.30M | $110.95M | $106.50M | $94.50M | $101.53M | $115.00M | $113.68M | $109.77M | $110.90M | $120.25M | $109.07M | $102.91M | $96.56M | $120.57M | $103.11M | $95.32M |
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | 0.92% | - | 1.01% | 1.05% | 1.03% | 1.05% | - | 1.04% | 0.98% | 1.02% | - |
Sharecare's average Quarter revenue forecast for Mar 24 based on 0 analysts is $101.53M, with a low forecast of $101.53M, and a high forecast of $101.53M. SHCR's average Quarter revenue forecast represents a -3.56% decrease compared to the company's last Quarter revenue of $105.28M (Dec 23).
Sharecare EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | $-16.72M | $-10.31M | $-20.95M | $-19.76M | $-10.87M | $-12.51M | - | $-40.20M | $21.84M | $-22.04M | $-918.67K |
| Avg Forecast | $-5.73M | $-5.60M | $-4.93M | $-4.75M | $-5.36M | $-5.15M | $-4.57M | $-4.91M | $-5.56M | $-5.49M | $-5.30M | $-5.36M | $-5.81M | $-5.27M | $-4.97M | $-4.68M | $-5.85M | $-5.00M | $-4.62M |
| High Forecast | $-5.73M | $-5.60M | $-4.93M | $-4.75M | $-5.36M | $-5.15M | $-4.57M | $-4.91M | $-5.56M | $-5.49M | $-5.30M | $-5.36M | $-5.81M | $-5.27M | $-4.97M | $-4.67M | $-5.83M | $-4.98M | $-4.61M |
| Low Forecast | $-5.73M | $-5.60M | $-4.93M | $-4.75M | $-5.36M | $-5.15M | $-4.57M | $-4.91M | $-5.56M | $-5.49M | $-5.30M | $-5.36M | $-5.81M | $-5.27M | $-4.97M | $-4.70M | $-5.87M | $-5.02M | $-4.64M |
| Surprise % | - | - | - | - | - | - | - | - | 3.01% | 1.88% | 3.95% | 3.69% | 1.87% | 2.37% | - | 8.58% | -3.73% | 4.41% | 0.20% |
0 analysts predict SHCR's average Quarter EBITDA for Mar 22 to be $-4.68M, with a high of $-4.67M and a low of $-4.70M. This is -121.45% lower than Sharecare's previous annual EBITDA (Dec 21) of $21.84M.
Sharecare Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | $-34.24M | $-24.45M | $-35.14M | $-35.01M | $-24.20M | $-27.46M | - | $-38.30M | $6.52M | $-43.12M | $-918.67K |
| Avg Forecast | $-12.61M | $-16.22M | $-16.22M | $-18.02M | $-14.42M | $-15.62M | $-18.02M | $-19.82M | $-8.41M | $-8.41M | $-9.01M | $-12.61M | $-10.81M | $-9.91M | $-21.25M | $-14.06M | $-11.07M | $-10.97M | $-5.14B |
| High Forecast | $-12.61M | $-16.22M | $-16.22M | $-18.02M | $-14.42M | $-15.62M | $-18.02M | $-19.82M | $-8.41M | $-8.41M | $-9.01M | $-12.61M | $-10.81M | $-9.91M | $-21.25M | $-13.99M | $-11.01M | $-10.92M | $-5.11B |
| Low Forecast | $-12.61M | $-16.22M | $-16.22M | $-18.02M | $-14.42M | $-15.62M | $-18.02M | $-19.82M | $-8.41M | $-8.41M | $-9.01M | $-12.61M | $-10.81M | $-9.91M | $-21.25M | $-14.13M | $-11.13M | $-11.03M | $-5.17B |
| Surprise % | - | - | - | - | - | - | - | - | 4.07% | 2.91% | 3.90% | 2.78% | 2.24% | 2.77% | - | 2.72% | -0.59% | 3.93% | 0.00% |
Sharecare's average Quarter net income forecast for Mar 22 is $-14.06M, with a range of $-14.13M to $-13.99M. SHCR's average Quarter net income forecast represents a -315.76% decrease compared to the company's last Quarter net income of $6.52M (Dec 21).
Sharecare SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | $46.83M | $48.80M | $50.33M | $49.47M | $48.94M | $50.58M | - | $70.51M | $66.89M | $75.13M | $878.37K |
| Avg Forecast | $46.70M | $45.60M | $40.20M | $38.71M | $43.69M | $41.93M | $37.21M | $39.98M | $45.28M | $44.76M | $43.22M | $43.67M | $47.35M | $42.95M | $40.52M | $38.17M | $47.67M | $40.76M | $37.68M |
| High Forecast | $46.70M | $45.60M | $40.20M | $38.71M | $43.69M | $41.93M | $37.21M | $39.98M | $45.28M | $44.76M | $43.22M | $43.67M | $47.35M | $42.95M | $40.52M | $38.32M | $47.85M | $40.92M | $37.83M |
| Low Forecast | $46.70M | $45.60M | $40.20M | $38.71M | $43.69M | $41.93M | $37.21M | $39.98M | $45.28M | $44.76M | $43.22M | $43.67M | $47.35M | $42.95M | $40.52M | $38.02M | $47.48M | $40.60M | $37.53M |
| Surprise % | - | - | - | - | - | - | - | - | 1.03% | 1.09% | 1.16% | 1.13% | 1.03% | 1.18% | - | 1.85% | 1.40% | 1.84% | 0.02% |
Sharecare's average Quarter SG&A projection for Mar 24 is $39.98M, based on 0 Wall Street analysts, with a range of $39.98M to $39.98M. The forecast indicates a -14.63% fall compared to SHCR last annual SG&A of $46.83M (Dec 23).
Sharecare EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | - | 1 | - | - | 1 | - | - | - | - | - | - | - | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | $-0.10 | $-0.07 | $-0.10 | $-0.10 | $-0.07 | $-0.08 | - | $-0.11 | $0.02 | $-0.13 | $-0.06 |
| Avg Forecast | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.04 | $-0.04 | $-0.05 | $-0.06 | $-0.02 | $-0.02 | $-0.03 | $-0.04 | $-0.03 | $-0.03 | $-0.06 | $-0.04 | $-0.03 | $-0.03 | $-14.62 |
| High Forecast | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.04 | $-0.04 | $-0.05 | $-0.06 | $-0.02 | $-0.02 | $-0.03 | $-0.04 | $-0.03 | $-0.03 | $-0.06 | $-0.04 | $-0.03 | $-0.03 | $-14.54 |
| Low Forecast | $-0.04 | $-0.04 | $-0.04 | $-0.05 | $-0.04 | $-0.04 | $-0.05 | $-0.06 | $-0.02 | $-0.02 | $-0.03 | $-0.04 | $-0.03 | $-0.03 | $-0.06 | $-0.04 | $-0.03 | $-0.03 | $-14.69 |
| Surprise % | - | - | - | - | - | - | - | - | 4.17% | 2.98% | 3.97% | 2.83% | 2.32% | 2.85% | - | 2.75% | -0.62% | 4.16% | 0.00% |
According to 0 Wall Street analysts, Sharecare's projected average Quarter EPS for Mar 22 is $-0.04, with a low estimate of $-0.04 and a high estimate of $-0.04. This represents a -305.13% decrease compared to SHCR previous annual EPS of $0.02 (Dec 21).
Sharecare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HCAT | Health Catalyst | $8.70 | $29.25 | 236.21% | Buy |
| SHCR | Sharecare | $1.40 | $3.14 | 124.29% | Buy |
| FORA | Forian | $2.22 | $4.50 | 102.70% | Buy |
| DH | Definitive Healthcare | $4.74 | $9.50 | 100.42% | Hold |
| PRVA | Privia Health Group | $18.80 | $33.82 | 79.89% | Buy |
| EVH | Evolent Health | $30.54 | $44.00 | 44.07% | Buy |
| HQY | HealthEquity | $78.80 | $97.00 | 23.10% | Buy |
SHCR Forecast FAQ
Is Sharecare a good buy?
Yes, according to 3 Wall Street analysts, Sharecare (SHCR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of SHCR's total ratings.
What is SHCR's price target?
Sharecare (SHCR) average price target is $3.14 with a range of $1.43 to $5, implying a 122.70% from its last price of $1.41. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Sharecare stock go up soon?
According to Wall Street analysts' prediction for SHCR stock, the company can go up by 122.70% (from the last price of $1.41 to the average price target of $3.14), up by 254.61% based on the highest stock price target, and up by 1.42% based on the lowest stock price target.
Can Sharecare stock reach $2?
SHCR's average twelve months analyst stock price target of $3.14 supports the claim that Sharecare can reach $2 in the near future.
What are Sharecare's analysts' financial forecasts?
Sharecare's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $413.48M (high $413.48M, low $413.48M), average EBITDA is $-19.978M (high $-19.978M, low $-19.978M), average net income is $-67.875M (high $-67.875M, low $-67.875M), average SG&A $162.81M (high $162.81M, low $162.81M), and average EPS is $-0.188 (high $-0.188, low $-0.188). SHCR's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $434.8M (high $434.8M, low $434.8M), average EBITDA is $-21.008M (high $-21.008M, low $-21.008M), average net income is $-63.07M (high $-63.07M, low $-63.07M), average SG&A $171.2M (high $171.2M, low $171.2M), and average EPS is $-0.175 (high $-0.175, low $-0.175).
Did the SHCR's actual financial results beat the analysts' financial forecasts?
Based on Sharecare's last annual report (Dec 2023), the company's revenue was $445.25M, which missed the average analysts forecast of $449.34M by -0.91%. Apple's EBITDA was $-68.842M, beating the average prediction of $-21.711M by 217.09%. The company's net income was $-128M, beating the average estimation of $-38.443M by 234.26%. Apple's SG&A was $195.43M, beating the average forecast of $176.93M by 10.46%. Lastly, the company's EPS was $-0.36, beating the average prediction of $-0.107 by 237.50%. In terms of the last quarterly report (Dec 2023), Sharecare's revenue was $105.28M, missing the average analysts' forecast of $115M by -8.45%. The company's EBITDA was $-16.719M, beating the average prediction of $-5.556M by 200.90%. Sharecare's net income was $-34.245M, beating the average estimation of $-8.409M by 307.23%. The company's SG&A was $46.83M, beating the average forecast of $45.28M by 3.42%. Lastly, the company's EPS was $-0.0974, beating the average prediction of $-0.0233 by 317.43%